Elevated Depressive Symptoms, Antidepressant Use, and Diabetes in a Large Multiethnic National Sample of Postmenopausal Women

Division of Preventive and Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Diabetes care (Impact Factor: 7.74). 09/2011; 34(11):2390-2. DOI: 10.2337/dc11-1223
Source: PubMed

ABSTRACT To examine elevated depressive symptoms and antidepressant use in relation to diabetes incidence in the Women's Health Initiative.
A total of 161,808 postmenopausal women were followed for over an average of 7.6 years. Hazard ratios (HRs) estimating the effects of elevated depressive symptoms and antidepressant use on newly diagnosed incident diabetes were obtained using Cox proportional hazards models adjusted for known diabetes risk factors.
Multivariable-adjusted HRs indicated an increased risk of incident diabetes with elevated baseline depressive symptoms (HR 1.13 [95% CI 1.07-1.20]) and antidepressant use (1.18 [1.10-1.28]). These associations persisted through year 3 data, in which respective adjusted HRs were 1.23 (1.09-1.39) and 1.31 (1.14-1.50).
Postmenopausal women with elevated depressive symptoms who also use antidepressants have a greater risk of developing incident diabetes. In addition, longstanding elevated depressive symptoms and recent antidepressant medication use increase the risk of incident diabetes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. Physical inactivity and advanced age are associated with risk of depressive disorders. Physical activity can reduce depressive symptoms in older subjects with depressive disorders. We investigated whether a walking intervention program may decrease the occurrence of depressive symptoms in inactive postmenopausal women without depression. Method. A total of 121 participants aged 57-75 years were randomly assigned to a 6-month moderate intensity walking intervention (3 times a week, 40 minutes per session, supervised and home-based) or to a control group (waiting list). Inactivity was assessed using the Physical Activity Questionnaire for the Elderly. Depression levels were measured pre- and post-intervention with the Beck Depression Inventory (BDI). Several baseline measures were considered as possible predictors of post-intervention BDI score. Results. Participants in the walking intervention showed a significant decrease in depression compared with controls. Baseline cognitive-BDI subscore, subjective health status, body mass index and adherence were post-intervention BDI score predictors. Conclusion. A 6-month, 3-session/week, moderate intensity walking intervention with a minimal 50% adherence rate reduces depression in postmenopausal women at risk for depression due to physical inactivity. This type of walking intervention could be considered as a widely accessible prevention strategy to prevent depressive symptoms in postmenopausal women at risk of depression.
    Aging and Mental Health 08/2014; DOI:10.1080/13607863.2014.948806 · 1.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aims We evaluated the association of combined use ofantidepressants andstatinsand the risk of new-onset diabetes among high-risk adults. Methods We used a retrospective, observational, longitudinal design among adults (age≥22 years) who were diabetes free at baseline and had reported hypertension or hyperlipidemia or heart disease. We used data were from 2004-2009 Medical Expenditure panel Survey and identified from self-reported diabetes or insulin use. We categorized antidepressants andstatins use into four groups: antidepressants only, statins only, combined use of antidepressants and statins (antidepressants-statins), and neither antidepressant nor statins.We conducted chi-square and multivariable logistic regressions to examine the association between use of antidepressants-statinsand new-onset diabetes after controlling fordemographic and economic characteristics, health-status, access to care, presence of depression, and lifestyle risk factors. Results In our study sample, 9.3% used antidepressants only, 10.7% used statins only and 2.4% adults reported use of antidepressants-statins. Nearly 2% of the study sample reportednew-onset diabetes. In unadjusted analyses, significantly higher proportion of adults using antidepressants-statins (3.2%) reported new-onset diabetes compared to those using neither antidepressants nor statins (1.1%).However, after controlling for all other variables in multivariable regression we did not observe a statistically significant association between use of antidepressants-statins and new-onset diabetes. Conclusions Our study results do not suggest that use ofantidepressants-statins may increase the risk of new-onset diabetes. Future research needs to examine this relationship with specific combinations of these drug classes and using longer follow up periods.
    Diabetes Research and Clinical Practice 08/2014; 105(2). DOI:10.1016/j.diabres.2014.04.016 · 2.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background The aim of the present study was to examine the association between antidepressant use, diagnosed depression, and new-onset diabetes among elderly Medicare beneficiaries. Methods Longitudinal data from merged survey and claims from the nationally representative Medicare Current Beneficiary Survey(MCBS) from 1999 to 2005 were used. Diabetes incidence was extracted from claims and survey data over a 3-year period. Data regarding depression and antidepressant use over time were obtained. Multivariate logistic regression analysis was used to examine associations between antidepressant use, depression, and new-onset diabetes, adjusted for demographic, socioeconomic, and lifestyle risk factors. Analyses accounted for the complex design of the MCBS. ResultsThe incident diabetes rate was 4.8% for those “without depression and without antidepressants” and 9.5% for those with any antidepressant use in all 3 years and diagnosed depression”. Compared with Medicare beneficiaries who did not report any antidepressant use, beneficiaries reporting antidepressant use in all 3 years were 50% more likely to have new-onset diabetes. However, when diagnosed depression was entered in the model, there was no significant association between long-term antidepressant use and new-onset diabetes. Medicare beneficiaries with any depression were twice as likely as those without depression to develop diabetes (adjusted odds ratio 2.04; 95% confidence interval 1.51, 2.75). Conclusions Depression independently increased the risk of developing diabetes in the MCBS population, although there is no evidence of an association between antidepressant use and new-onset diabetes. If replicated, these results have significant clinical implications. 摘要 背景本研究的目的是在老年医疗保险受益者中调查抗抑郁药的使用、抑郁症的诊断与新发糖尿病之间的关系。 方法纵向数据来自于合并的调查与索赔数据,即1999至2005年间全国典型的医疗保险当前受益人调查(Medicare Current Beneficiary Survey MCBS)数据。糖尿病发生率来自于超过3年的索赔与调查数据。并获取有关抑郁症以及随着时间的推移抗抑郁药使用情况的数据。使用多因素Logistic回归分析来检验抗抑郁药的使用情况以及抑郁症与新发糖尿病之间的关系,并且经过了人口统计学、社会经济学以及生活方式等危险因素的校正。分析解释了MCBS的复杂设计。 结果那些“没有抑郁症也没有使用抗抑郁药物”的老年人糖尿病发生率为4.8%,那些“使用任何抗抑郁药物总共达到3年以及已经诊断抑郁症”的老年人糖尿病发生率为9.5%。与那些没有报告使用任何抗抑郁药的医疗保险受益者相比较,报告使用任何抗抑郁药物总共达到3年的受益者出现新发糖尿病的可能性高50%。然而,若将已经诊断的抑郁症也并入模型中,则长期使用抗抑郁药与新发糖尿病之间就没有显著的相关性了。合并任何程度抑郁症的医疗保险受益者发生糖尿病的可能性是那些未合并抑郁症受益者的2倍(校正后优势比为2.04;95%CI为1.51,2.75)。 结论在MCBS人群中,抑郁症可独立增加患糖尿病的风险,虽然目前还没有证据表明抗抑郁药的使用与新发糖尿病之间具有相关性。如果能够得到重复研究的证实,那么这些结果将具有重要的临床意义。
    Journal of Diabetes 09/2013; 5(3). DOI:10.1111/1753-0407.12014 · 2.94 Impact Factor

Full-text (2 Sources)

Available from
May 19, 2014